Drug profile · INN
dextrothyroxine sodium
CHOLOXIN
dextrothyroxine sodium (CHOLOXIN) is a thyroid hormone receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — dextrothyroxine sodium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
dextrothyroxine sodium (CHOLOXIN) is a thyroid hormone receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thyroid hormone receptor agonist
Primary target: Thyroid hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is dextrothyroxine sodium?
dextrothyroxine sodium (CHOLOXIN) is a thyroid hormone receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for dextrothyroxine sodium?
CHOLOXIN is a marketed brand name for dextrothyroxine sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dextrothyroxine sodium?
dextrothyroxine sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.